Table 4.
Test | Patients |
---|---|
Physical examination | All patients |
Ultrasonography of the testes | All patients |
Serum tumour markers | All patients |
AFP | |
β-hCG | |
LDH | |
Chest/abdominal/pelvic CT | All patients |
Cranial MRI | Symptomatic patients and patients in the IGCCCG poor prognosis group, or patients with multiple pulmonary metastases and/or high β-hCG values (>5,000 IU/L) |
Further diagnostics | Patients with unfinished family planning, active or postponed desire for offspring as well as for ruling out/detecting hypogonadism |
Fertility tests | |
Sperm analysis/cryopreservation | |
Testosterone | |
LH | |
FSH |
AFP, α-fetoprotein; hCG, human chorionic gonadotropin; LDH, lactate dehydrogenase; CT, computed tomography; IGCCCG, International Germ Cell Cancer Collaboration Group; LH, luteinizing hormone; FSH, follicle-stimulating hormone. We recommend advising all patients on the cryopreservation of sperm preferably before the primary surgical intervention and, if necessary, arrange consultation with an andrologist or a fertility centre.